Methylation of tumour suppressor genes associated with thyroid cancer-Reference-Cited by-同舟云学术

Methylation of tumour suppressor genes associated with thyroid cancer

Published:2019-05-20 Issue:1 Volume:25 Page:53-65
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Botezatu Anca¹,Iancu Iulia V.¹,Plesa Adriana¹,Manda Dana²,Popa Oana²,Bostan Marinela¹,Mihaila Mirela¹,Albulescu Adrian¹³,Fudulu Alina¹,Vladoiu Susana V.²,Huica Irina¹,Dobrescu Ruxandra²⁴,Anton Gabriela¹,Badiu Corin²⁴

Affiliation:

1. ‘Stefan S. Nicolau’ Institute of Virology, Bucharest, Romania

2. ‘CI Parhon’ National Institute of Endocrinology, Bucharest, Romania

3. National Institute for Chemical pharmaceutical Research and Development, Calea Vitan, Romania

4. ‘Carol Davila’ University of Medicine and Pharmacy, Bucharest, Romania

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference60 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. and General Considerations of Thyroid Cancer;Katoh;Ann Clin Pathol,2015

3. Thyroid cancer: Zealous imaging has increased detection and treatment of low risk tumours;Brito;BMJ,2013

4. Cancer epigenetics: From mechanism to therapy;Dawson;Cell,2012

5. Molecular genetics and diagnosis of thyroid cancer;Nikiforov;Nat Rev Endocrinol,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy;BMC Cancer;2023-11-13

2. Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches;Life Sciences;2023-11

3. Novel Bovine Serum Albumin-Decorated–Nanostructured Lipid Carriers Able to Modulate Apoptosis and Cell-Cycle Response in Ovarian, Breast, and Colon Tumoral Cells;Pharmaceutics;2023-04-02

4. Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma;Cancer Cell International;2022-12-12

5. Clinical importance of PLA2R1 and RASSF9 in thyroid cancer and their inhibitory roles on the Wnt/β-catenin pathway and thyroid cancer cell malignant behaviors;Pathology - Research and Practice;2022-10